László Szapáry

1.2k total citations
58 papers, 542 citations indexed

About

László Szapáry is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, László Szapáry has authored 58 papers receiving a total of 542 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Epidemiology, 21 papers in Cardiology and Cardiovascular Medicine and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in László Szapáry's work include Acute Ischemic Stroke Management (31 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). László Szapáry is often cited by papers focused on Acute Ischemic Stroke Management (31 papers), Cerebrovascular and Carotid Artery Diseases (13 papers) and Antiplatelet Therapy and Cardiovascular Diseases (11 papers). László Szapáry collaborates with scholars based in Hungary, Denmark and United Kingdom. László Szapáry's co-authors include Gergely Fehér, Gabriella Pusch, Andrea Fehér, Kálmán Tóth, Előd Papp, Gábor Késmárky, Beáta Horváth, Tihamér Molnár, Zsolt Márton and Tamás Alexy and has published in prestigious journals such as PLoS ONE, Journal of Clinical Pathology and BioMed Research International.

In The Last Decade

László Szapáry

51 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
László Szapáry Hungary 13 181 166 98 96 77 58 542
Lulu Pei China 14 91 0.5× 174 1.0× 61 0.6× 69 0.7× 92 1.2× 37 536
Guangyao Wang China 11 270 1.5× 209 1.3× 99 1.0× 144 1.5× 75 1.0× 16 586
Zsolt Márton Hungary 11 160 0.9× 62 0.4× 137 1.4× 111 1.2× 75 1.0× 32 520
Song Tan China 12 60 0.3× 225 1.4× 84 0.9× 43 0.4× 115 1.5× 24 534
Sohel Zaedi Japan 17 184 1.0× 134 0.8× 111 1.1× 70 0.7× 183 2.4× 41 680
Francesco Piarulli Italy 16 295 1.6× 103 0.6× 98 1.0× 129 1.3× 95 1.2× 38 981
P. M. Ridker United States 9 289 1.6× 158 1.0× 61 0.6× 207 2.2× 165 2.1× 11 877
Mario Pacileo Italy 18 407 2.2× 174 1.0× 80 0.8× 147 1.5× 140 1.8× 33 884
Akira Suehiro Japan 14 141 0.8× 110 0.7× 83 0.8× 112 1.2× 90 1.2× 54 745
Miao Chen China 17 45 0.2× 170 1.0× 73 0.7× 99 1.0× 186 2.4× 53 643

Countries citing papers authored by László Szapáry

Since Specialization
Citations

This map shows the geographic impact of László Szapáry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by László Szapáry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites László Szapáry more than expected).

Fields of papers citing papers by László Szapáry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by László Szapáry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by László Szapáry. The network helps show where László Szapáry may publish in the future.

Co-authorship network of co-authors of László Szapáry

This figure shows the co-authorship network connecting the top 25 collaborators of László Szapáry. A scholar is included among the top collaborators of László Szapáry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with László Szapáry. László Szapáry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosnyák, Edit, et al.. (2025). Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes. Journal of Personalized Medicine. 15(1). 18–18.
2.
Szapáry, László, et al.. (2025). Ischaemiás stroke Európában: incidenciatrendek három évtized távlatában (1991–2021). Orvosi Hetilap. 166(42). 1642–1652.
3.
Bosnyák, Edit, et al.. (2025). Pre-Admission Antiplatelet Therapy in Cryptogenic Stroke: A Double-Edged Sword. Journal of Clinical Medicine. 14(4). 1061–1061. 1 indexed citations
5.
Szapáry, László, et al.. (2024). Learning Curve for Starting a Successful Single-Centre TAVR Programme with Multiple Devices: Early and Mid-Term Follow-Up. Journal of Clinical Medicine. 13(4). 1088–1088.
6.
Bosnyák, Edit, et al.. (2024). Bridging the Gap: Improving Acute Ischemic Stroke Outcomes with Intravenous Thrombolysis Prior to Mechanical Thrombectomy. Neurology International. 16(6). 1189–1202. 2 indexed citations
7.
Szapáry, László, et al.. (2024). Single-Center Experience with the Balloon-Expandable Myval Transcatheter Aortic Valve System in Patients with Bicuspid Anatomy: Procedural and 30-Day Follow-Up. Journal of Clinical Medicine. 13(2). 513–513. 3 indexed citations
8.
Szapáry, László, et al.. (2023). Single center experience with the balloon‐expandable Myval transcatheter aortic valve system with the first 100 patients: 30‐day and 1‐year follow‐up. Catheterization and Cardiovascular Interventions. 102(7). 1317–1330. 5 indexed citations
9.
Csécsei, Péter, et al.. (2021). Capability of stroke scales to detect large vessel occlusion in acute ischemic stroke : A pilot study. Ideggyógyászati Szemle. 74(3-4). 99–103. 2 indexed citations
10.
Ezer, Erzsébet, et al.. (2021). Novel Predictors of Future Vascular Events in Post-stroke Patients—A Pilot Study. Frontiers in Neurology. 12. 666994–666994. 4 indexed citations
11.
Fehér, Gergely, Péter Csécsei, Judit Papp, et al.. (2020). The Role of Adjuvant Vinpocetine Therapy in Aspirin-Treated Cerebrovascular Patients. 7(1). 942–945. 2 indexed citations
12.
Csécsei, Péter, Edit Bosnyák, László Szapáry, et al.. (2020). Risk analysis of post-procedural intracranial hemorrhage based on STAY ALIVE Acute Stroke Registry. Journal of Stroke and Cerebrovascular Diseases. 29(7). 104851–104851. 9 indexed citations
13.
Csécsei, Péter, Réka Várnai, L Nagy, et al.. (2019). L-arginine pathway metabolites can discriminate paroxysmal from permanent atrial fibrillation in acute ischemic stroke. Ideggyógyászati Szemle. 72(3-4). 79–88. 8 indexed citations
14.
Ezer, Erzsébet, et al.. (2019). A novel approach of platelet function test for prediction of attenuated response to clopidogrel. Clinical Hemorheology and Microcirculation. 73(2). 359–369. 13 indexed citations
15.
Csécsei, Péter, Gabriella Pusch, Erzsébet Ezer, et al.. (2017). Relationship between Cardiac Troponin and Thrombo-Inflammatory Molecules in Prediction of Outcome after Acute Ischemic Stroke. Journal of Stroke and Cerebrovascular Diseases. 27(4). 951–956. 12 indexed citations
16.
Fehér, Gergely, Antal Tibold, Katalin Koltai, & László Szapáry. (2014). The Clinical Importance of Troponin Elevation in Ischaemic Cerebrovascular Events: A Clinical Review. 1(7). 141–149. 3 indexed citations
17.
Tóth, Péter, Ákos Koller, Gabriella Pusch, et al.. (2010). Microalbuminuria, Indicated by Total versus Immunoreactive Urinary Albumins, in Acute Ischemic Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. 20(6). 510–516. 11 indexed citations
18.
Fehér, Andrea, Gabriella Pusch, Katalin Koltai, et al.. (2010). Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases. International Journal of Cardiology. 148(2). 131–138. 12 indexed citations
19.
Molnár, Tihamér, Ágnes Péterfalvi, László Szereday, et al.. (2008). Deficient leucocyte antisedimentation is related to post-stroke infections and outcome. Journal of Clinical Pathology. 61(11). 1209–1213. 10 indexed citations
20.
Papp, Előd, Viktória Havasi, Judit Bene, et al.. (2007). Does Glycoprotein IIIa Gene (PlA) Polymorphism Influence Clopidogrel Resistance?. Drugs & Aging. 24(4). 345–350. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026